Insecticides Intrinsic Value
Insecticides (INSECTICID) median intrinsic value is ₹707.31 from 9 valuation models (range ₹306–₹1302), vs current price ₹765.10 — -7.6% downside (Trading Near Calculated Value), margin of safety -8.2%. Browse INSECTICID income statement for revenue, profit, balance sheet and cash flow data.
INSECTICID Valuation Methods Summary — DCF, Graham Number & P/E
Insecticides intrinsic value across 9 models vs current price ₹765.10 — upside/downside and value range per method. Also explore INSECTICID share price data to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹974.88 | ₹779.90 - ₹1169.86 | +27.4% | EPS: ₹81.24, Sector P/E: 12x |
| Book Value Method | asset | ₹374.14 | ₹336.73 - ₹411.55 | -51.1% | Book Value/Share: ₹374.14, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹707.31 | ₹636.58 - ₹778.04 | -7.6% | Revenue/Share: ₹884.14, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹761.38 | ₹685.24 - ₹837.52 | -0.5% | EBITDA: ₹368.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹306.04 | ₹244.83 - ₹367.25 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹519.94 | ₹467.95 - ₹571.93 | -32.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹669.42 | ₹602.48 - ₹736.36 | -12.5% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1302.07 | ₹1171.86 - ₹1432.28 | +70.2% | ROE: 21.8%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹748.28 | ₹673.45 - ₹823.11 | -2.2% | EPS: ₹81.24, BVPS: ₹374.14 |
INSECTICID Intrinsic Value vs Market Price — All Valuation Models
Insecticides fair value range ₹306–₹1302 vs current market price ₹765.10 across 9 valuation models. For current market price and key ratios, visit Insecticides screener.
INSECTICID Intrinsic Value Analysis — Undervalued or Overvalued?
Insecticides median intrinsic value ₹707.31, current price ₹765.10 — Trading Near Calculated Value by 7.6%, margin of safety -8.2%.
What is the intrinsic value of INSECTICID?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Insecticides (INSECTICID) is ₹707.31 (median value). With the current market price of ₹765.10, this represents a -7.6% variance from our estimated fair value.
The valuation range spans from ₹306.04 to ₹1302.07, indicating ₹306.04 - ₹1302.07.
Is INSECTICID undervalued or overvalued?
Based on our multi-method analysis, Insecticides (INSECTICID) appears to be trading near calculated value by approximately 7.6%.
INSECTICID Financial Health — Key Ratios vs Industry Benchmarks
Insecticides financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 39.58 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 21.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.35x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
INSECTICID Cash Flow Quality — Operating & Free Cash Flow
Insecticides operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹94 Cr | ₹75 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹187 Cr | ₹164 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-11 Cr | ₹-54 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹135 Cr | ₹135 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹155 Cr | ₹99 Cr | Positive Free Cash Flow | 8/10 |